Global Pharmaceutical Contract Development and Manufacturing Organization Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Format: PDF   |   Report ID: 5513403   |   Published Date: August 2022   |   Pages:  111  

Choose License
The Pharmaceutical Contract Development and Manufacturing Organization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceutical Contract Development and Manufacturing Organization market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Large Enterprise accounting for  % of the Pharmaceutical Contract Development and Manufacturing Organization global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While API Development segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Pharmaceutical Contract Development and Manufacturing Organization include Catalent, Recipharm, Jubilant Life Sciences, Patheon Inc., and Boehringer Ingelheim, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Pharmaceutical Contract Development and Manufacturing Organization market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

    API Development
    Pharmaceutical Manufacturing

Market segment by Application, can be divided into

    Large Enterprise
    SME

Market segment by players, this report covers

    Catalent
    Recipharm
    Jubilant Life Sciences
    Patheon Inc.
    Boehringer Ingelheim
    Pfizer Centreone
    Aenova Group
    Famar
    Baxter Pharmaceutical Solutions
    Lonza Group
    Tesa Labtec
    Tapemark
    ARX LLC
    Cambrex
    Samsung Biologics
    Fujifilm Diosynth Biotechnologies
    WuXi Biologics
    Center for Breakthrough Medicines (CBM)
    Siegfried AG

Market segment by regions, regional analysis covers

    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pharmaceutical Contract Development and Manufacturing Organization product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pharmaceutical Contract Development and Manufacturing Organization, with revenue, gross margin and global market share of Pharmaceutical Contract Development and Manufacturing Organization from 2019 to 2022.
Chapter 3, the Pharmaceutical Contract Development and Manufacturing Organization competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Contract Development and Manufacturing Organization market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pharmaceutical Contract Development and Manufacturing Organization research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Product Overview and Scope of Pharmaceutical Contract Development and Manufacturing Organization
    1.2 Classification of Pharmaceutical Contract Development and Manufacturing Organization by Type
        1.2.1 Overview: Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type in 2021
        1.2.3 API Development
        1.2.4 Pharmaceutical Manufacturing
    1.3 Global Pharmaceutical Contract Development and Manufacturing Organization Market by Application
        1.3.1 Overview: Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Large Enterprise
        1.3.3 SME
    1.4 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size & Forecast
    1.5 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast by Region
        1.5.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region, (2017-2022)
        1.5.3 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2017-2028)
        1.5.4 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2017-2028)
        1.5.6 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Pharmaceutical Contract Development and Manufacturing Organization Market Drivers
        1.6.2 Pharmaceutical Contract Development and Manufacturing Organization Market Restraints
        1.6.3 Pharmaceutical Contract Development and Manufacturing Organization Trends Analysis
2 Company Profiles
    2.1 Catalent
        2.1.1 Catalent Details
        2.1.2 Catalent Major Business
        2.1.3 Catalent Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.1.4 Catalent Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Catalent Recent Developments and Future Plans
    2.2 Recipharm
        2.2.1 Recipharm Details
        2.2.2 Recipharm Major Business
        2.2.3 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.2.4 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Recipharm Recent Developments and Future Plans
    2.3 Jubilant Life Sciences
        2.3.1 Jubilant Life Sciences Details
        2.3.2 Jubilant Life Sciences Major Business
        2.3.3 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.3.4 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Jubilant Life Sciences Recent Developments and Future Plans
    2.4 Patheon Inc.
        2.4.1 Patheon Inc. Details
        2.4.2 Patheon Inc. Major Business
        2.4.3 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.4.4 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Patheon Inc. Recent Developments and Future Plans
    2.5 Boehringer Ingelheim
        2.5.1 Boehringer Ingelheim Details
        2.5.2 Boehringer Ingelheim Major Business
        2.5.3 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.5.4 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.6 Pfizer Centreone
        2.6.1 Pfizer Centreone Details
        2.6.2 Pfizer Centreone Major Business
        2.6.3 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.6.4 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Pfizer Centreone Recent Developments and Future Plans
    2.7 Aenova Group
        2.7.1 Aenova Group Details
        2.7.2 Aenova Group Major Business
        2.7.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.7.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Aenova Group Recent Developments and Future Plans
    2.8 Famar
        2.8.1 Famar Details
        2.8.2 Famar Major Business
        2.8.3 Famar Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.8.4 Famar Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Famar Recent Developments and Future Plans
    2.9 Baxter Pharmaceutical Solutions
        2.9.1 Baxter Pharmaceutical Solutions Details
        2.9.2 Baxter Pharmaceutical Solutions Major Business
        2.9.3 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.9.4 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Baxter Pharmaceutical Solutions Recent Developments and Future Plans
    2.10 Lonza Group 
        2.10.1 Lonza Group Details
        2.10.2 Lonza Group Major Business
        2.10.3 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.10.4 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Lonza Group Recent Developments and Future Plans
    2.11 Tesa Labtec
        2.11.1 Tesa Labtec Details
        2.11.2 Tesa Labtec Major Business
        2.11.3 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.11.4 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Tesa Labtec Recent Developments and Future Plans
    2.12 Tapemark
        2.12.1 Tapemark Details
        2.12.2 Tapemark Major Business
        2.12.3 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.12.4 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Tapemark Recent Developments and Future Plans
    2.13 ARX LLC
        2.13.1 ARX LLC Details
        2.13.2 ARX LLC Major Business
        2.13.3 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.13.4 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 ARX LLC Recent Developments and Future Plans
    2.14 Cambrex
        2.14.1 Cambrex Details
        2.14.2 Cambrex Major Business
        2.14.3 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.14.4 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Cambrex Recent Developments and Future Plans
    2.15 Samsung Biologics
        2.15.1 Samsung Biologics Details
        2.15.2 Samsung Biologics Major Business
        2.15.3 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.15.4 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Samsung Biologics Recent Developments and Future Plans
    2.16 Fujifilm Diosynth Biotechnologies
        2.16.1 Fujifilm Diosynth Biotechnologies Details
        2.16.2 Fujifilm Diosynth Biotechnologies Major Business
        2.16.3 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.16.4 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
    2.17 WuXi Biologics
        2.17.1 WuXi Biologics Details
        2.17.2 WuXi Biologics Major Business
        2.17.3 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.17.4 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 WuXi Biologics Recent Developments and Future Plans
    2.18 Center for Breakthrough Medicines (CBM)
        2.18.1 Center for Breakthrough Medicines (CBM) Details
        2.18.2 Center for Breakthrough Medicines (CBM) Major Business
        2.18.3 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.18.4 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 Center for Breakthrough Medicines (CBM) Recent Developments and Future Plans
    2.19 Siegfried AG
        2.19.1 Siegfried AG Details
        2.19.2 Siegfried AG Major Business
        2.19.3 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
        2.19.4 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.19.5 Siegfried AG Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Pharmaceutical Contract Development and Manufacturing Organization Players Market Share in 2021
        3.2.2 Top 10 Pharmaceutical Contract Development and Manufacturing Organization Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Pharmaceutical Contract Development and Manufacturing Organization Players Head Office, Products and Services Provided
    3.4 Pharmaceutical Contract Development and Manufacturing Organization Mergers & Acquisitions
    3.5 Pharmaceutical Contract Development and Manufacturing Organization New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue and Market Share by Type (2017-2022)
    4.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2017-2022)
    5.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2028)
    6.2 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2028)
    6.3 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country
        6.3.1 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2017-2028)
        6.3.2 United States Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        6.3.3 Canada Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        6.3.4 Mexico Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2028)
    7.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2028)
    7.3 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country
        7.3.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2017-2028)
        7.3.2 Germany Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        7.3.3 France Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        7.3.5 Russia Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        7.3.6 Italy Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2028)
    8.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2028)
    8.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region
        8.3.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue by Region (2017-2028)
        8.3.2 China Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        8.3.3 Japan Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        8.3.4 South Korea Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        8.3.5 India Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        8.3.7 Australia Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2028)
    9.2 South America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2028)
    9.3 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country
        9.3.1 South America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2017-2028)
        9.3.2 Brazil Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        9.3.3 Argentina Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2028)
    10.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2028)
    10.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country
        10.3.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2017-2028)
        10.3.2 Turkey Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
        10.3.4 UAE Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type, (USD Million), 2017 VS 2021 VS 2028 Table 2. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application, (USD Million), 2017 VS 2021 VS 2028 Table 3. Global Market Pharmaceutical Contract Development and Manufacturing Organization Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028) Table 4. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million) by Region (2017-2022) Table 5. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Region (2023-2028) Table 6. Catalent Corporate Information, Head Office, and Major Competitors Table 7. Catalent Major Business Table 8. Catalent Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 9. Catalent Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 10. Recipharm Corporate Information, Head Office, and Major Competitors Table 11. Recipharm Major Business Table 12. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 13. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 14. Jubilant Life Sciences Corporate Information, Head Office, and Major Competitors Table 15. Jubilant Life Sciences Major Business Table 16. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 17. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 18. Patheon Inc. Corporate Information, Head Office, and Major Competitors Table 19. Patheon Inc. Major Business Table 20. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 21. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 22. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors Table 23. Boehringer Ingelheim Major Business Table 24. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 25. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 26. Pfizer Centreone Corporate Information, Head Office, and Major Competitors Table 27. Pfizer Centreone Major Business Table 28. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 29. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 30. Aenova Group Corporate Information, Head Office, and Major Competitors Table 31. Aenova Group Major Business Table 32. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 33. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 34. Famar Corporate Information, Head Office, and Major Competitors Table 35. Famar Major Business Table 36. Famar Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 37. Famar Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 38. Baxter Pharmaceutical Solutions Corporate Information, Head Office, and Major Competitors Table 39. Baxter Pharmaceutical Solutions Major Business Table 40. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 41. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 42. Lonza Group Corporate Information, Head Office, and Major Competitors Table 43. Lonza Group Major Business Table 44. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 45. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 46. Tesa Labtec Corporate Information, Head Office, and Major Competitors Table 47. Tesa Labtec Major Business Table 48. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 49. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 50. Tapemark Corporate Information, Head Office, and Major Competitors Table 51. Tapemark Major Business Table 52. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 53. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 54. ARX LLC Corporate Information, Head Office, and Major Competitors Table 55. ARX LLC Major Business Table 56. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 57. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 58. Cambrex Corporate Information, Head Office, and Major Competitors Table 59. Cambrex Major Business Table 60. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 61. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 62. Samsung Biologics Corporate Information, Head Office, and Major Competitors Table 63. Samsung Biologics Major Business Table 64. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 65. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 66. Fujifilm Diosynth Biotechnologies Corporate Information, Head Office, and Major Competitors Table 67. Fujifilm Diosynth Biotechnologies Major Business Table 68. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 69. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 70. WuXi Biologics Corporate Information, Head Office, and Major Competitors Table 71. WuXi Biologics Major Business Table 72. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 73. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 74. Center for Breakthrough Medicines (CBM) Corporate Information, Head Office, and Major Competitors Table 75. Center for Breakthrough Medicines (CBM) Major Business Table 76. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 77. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 78. Siegfried AG Corporate Information, Head Office, and Major Competitors Table 79. Siegfried AG Major Business Table 80. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions Table 81. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 82. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million) by Players (2019, 2020, 2021, and 2022) Table 83. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Players (2019, 2020, 2021, and 2022) Table 84. Breakdown of Pharmaceutical Contract Development and Manufacturing Organization by Company Type (Tier 1, Tier 2 and Tier 3) Table 85. Pharmaceutical Contract Development and Manufacturing Organization Players Head Office, Products and Services Provided Table 86. Pharmaceutical Contract Development and Manufacturing Organization Mergers & Acquisitions in the Past Five Years Table 87. Pharmaceutical Contract Development and Manufacturing Organization New Entrants and Expansion Plans Table 88. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million) by Type (2017-2022) Table 89. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2017-2022) Table 90. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Forecast by Type (2023-2028) Table 91. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2022) Table 92. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Forecast by Application (2023-2028) Table 93. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2022) & (USD Million) Table 94. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2023-2028) & (USD Million) Table 95. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2022) & (USD Million) Table 96. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2023-2028) & (USD Million) Table 97. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2017-2022) & (USD Million) Table 98. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2023-2028) & (USD Million) Table 99. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2022) & (USD Million) Table 100. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2023-2028) & (USD Million) Table 101. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2022) & (USD Million) Table 102. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2023-2028) & (USD Million) Table 103. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2017-2022) & (USD Million) Table 104. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2023-2028) & (USD Million) Table 105. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2022) & (USD Million) Table 106. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2023-2028) & (USD Million) Table 107. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2022) & (USD Million) Table 108. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2023-2028) & (USD Million) Table 109. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue by Region (2017-2022) & (USD Million) Table 110. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue by Region (2023-2028) & (USD Million) Table 111. South America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2022) & (USD Million) Table 112. South America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2023-2028) & (USD Million) Table 113. South America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2022) & (USD Million) Table 114. South America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2023-2028) & (USD Million) Table 115. South America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2017-2022) & (USD Million) Table 116. South America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2023-2028) & (USD Million) Table 117. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2017-2022) & (USD Million) Table 118. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2023-2028) & (USD Million) Table 119. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2017-2022) & (USD Million) Table 120. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2023-2028) & (USD Million) Table 121. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2017-2022) & (USD Million) Table 122. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2023-2028) & (USD Million) List of Figures Figure 1. Pharmaceutical Contract Development and Manufacturing Organization Picture Figure 2. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type in 2021 Figure 3. API Development Figure 4. Pharmaceutical Manufacturing Figure 5. Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application in 2021 Figure 6. Large Enterprise Picture Figure 7. SME Picture Figure 8. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size, (USD Million): 2017 VS 2021 VS 2028 Figure 9. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue and Forecast (2017-2028) & (USD Million) Figure 10. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Region (2017-2028) Figure 11. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Region in 2021 Figure 12. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million) and Growth Rate (2017-2028) Figure 13. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million) and Growth Rate (2017-2028) Figure 14. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million) and Growth Rate (2017-2028) Figure 15. South America Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million) and Growth Rate (2017-2028) Figure 16. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million) and Growth Rate (2017-2028) Figure 17. Pharmaceutical Contract Development and Manufacturing Organization Market Drivers Figure 18. Pharmaceutical Contract Development and Manufacturing Organization Market Restraints Figure 19. Pharmaceutical Contract Development and Manufacturing Organization Market Trends Figure 20. Catalent Recent Developments and Future Plans Figure 21. Recipharm Recent Developments and Future Plans Figure 22. Jubilant Life Sciences Recent Developments and Future Plans Figure 23. Patheon Inc. Recent Developments and Future Plans Figure 24. Boehringer Ingelheim Recent Developments and Future Plans Figure 25. Pfizer Centreone Recent Developments and Future Plans Figure 26. Aenova Group Recent Developments and Future Plans Figure 27. Famar Recent Developments and Future Plans Figure 28. Baxter Pharmaceutical Solutions Recent Developments and Future Plans Figure 29. Lonza Group Recent Developments and Future Plans Figure 30. Tesa Labtec Recent Developments and Future Plans Figure 31. Tapemark Recent Developments and Future Plans Figure 32. ARX LLC Recent Developments and Future Plans Figure 33. Cambrex Recent Developments and Future Plans Figure 34. Samsung Biologics Recent Developments and Future Plans Figure 35. Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans Figure 36. WuXi Biologics Recent Developments and Future Plans Figure 37. Center for Breakthrough Medicines (CBM) Recent Developments and Future Plans Figure 38. Siegfried AG Recent Developments and Future Plans Figure 39. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Players in 2021 Figure 40. Pharmaceutical Contract Development and Manufacturing Organization Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021 Figure 41. Global Top 3 Players Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share in 2021 Figure 42. Global Top 10 Players Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share in 2021 Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022) Figure 44. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type in 2021 Figure 45. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share Forecast by Type (2023-2028) Figure 46. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application in 2021 Figure 47. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share Forecast by Application (2023-2028) Figure 48. North America Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Type (2017-2028) Figure 49. North America Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Application (2017-2028) Figure 50. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Country (2017-2028) Figure 51. United States Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 52. Canada Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 53. Mexico Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 54. Europe Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Type (2017-2028) Figure 55. Europe Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Application (2017-2028) Figure 56. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Country (2017-2028) Figure 57. Germany Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 58. France Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. United Kingdom Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Russia Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. Italy Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 62. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Type (2017-2028) Figure 63. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Application (2017-2028) Figure 64. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Region (2017-2028) Figure 65. China Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 66. Japan Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 67. South Korea Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 68. India Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 69. Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 70. Australia Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 71. South America Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Type (2017-2028) Figure 72. South America Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Application (2017-2028) Figure 73. South America Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Country (2017-2028) Figure 74. Brazil Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. Argentina Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 76. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Type (2017-2028) Figure 77. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Sales Market Share by Application (2017-2028) Figure 78. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Country (2017-2028) Figure 79. Turkey Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 80. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 81. UAE Pharmaceutical Contract Development and Manufacturing Organization Revenue and Growth Rate (2017-2028) & (USD Million) Figure 82. Methodology Figure 83. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us